One-year clinical outcomes of MR-guided stereotactic body radiation therapy with rectal spacer for patients with localized prostate cancer - Takeaways - MDSpire

One-year clinical outcomes of MR-guided stereotactic body radiation therapy with rectal spacer for patients with localized prostate cancer

  • By

  • Darren M. C. Poon

  • Jing Yuan

  • Oi Lei Wong

  • Bin Yang

  • Mei Yan Tse

  • Ka Ki Lau

  • Sin Ting Chiu

  • Peter Ka-Fung Chiu

  • Chi Fai Ng

  • Ka Lun Chui

  • Yiu Ming Kwong

  • Wai Kit Ma

  • Kin Yin Cheung

  • George Chiu

  • Siu Ki Yu

  • February 23, 2024

  • 0 min

Share

  • 1

    MR-guided stereotactic body radiation therapy (MRgSBRT) improves oncological outcomes and quality of life in localized prostate cancer patients.

  • 2

    Injectable rectal spacers increase the distance between the rectum and prostate, potentially reducing rectal toxicity during SBRT.

  • 3

    The study aimed to assess the clinical use of rectal spacers in MRgSBRT and report patient-reported outcomes up to one year post-treatment.

  • 4

    Patients eligible for the study included those with localized prostate adenocarcinoma and no prior pelvic irradiation or surgery.

  • 5

    Preliminary results suggest that rectal spacers enhance rectal sparing and target coverage in patients undergoing MRgSBRT.

Original Source(s)

One-year clinical outcomes of MR-guided stereotactic body radiation therapy with rectal spacer for patients with localized prostate cancer

  • by Darren M. C. Poon, Jing Yuan, Oi Lei Wong, Bin Yang, Mei Yan Tse, Ka Ki Lau, Sin Ting Chiu, Peter Ka-Fung Chiu, Chi Fai Ng, Ka Lun Chui, Yiu Ming Kwong, Wai Kit Ma, Kin Yin Cheung, George Chiu, Siu Ki Yu

  • February 23, 2024

Related Content

Radiotherapy in metastatic bladder cancer

Evaluating the Role of PSMA-PET in Enhancing Salvage Radiotherapy: A Discussion on Precision versus Timing

Polyethylene glycol-based hydrogel rectal spacers for prostate brachytherapy: a systematic review with a focus on technique